The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Arthrex sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Arthrex Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Arthrex designs and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and wrist, foot and ankle, and hip related surgical products, orthobiologics and imaging and resection systems. It also provides medical education; training programs; physician observation program; surgical outcomes system orthopedic and sports medicine global registry; and patient education. The company markets products directly and through a network of distributors in the Americas, Europe, the Middle East, Africa, and Asia. Arthrex is headquartered in Naples, Florida, the US. Key subsidiaries of Arthrex include Arthrex Adria, Arthrex Espana & Portugal S.L.U., Arthrex, Arthrex do Brazil and Arthrex Nederland.

The key metrics of Arthrex related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Arthrex is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Arthrex.

For a detailed understanding of the performance of Arthrex, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.